GB8901334D0 - Improvements relating to broadhead arrows - Google Patents
Improvements relating to broadhead arrowsInfo
- Publication number
- GB8901334D0 GB8901334D0 GB898901334A GB8901334A GB8901334D0 GB 8901334 D0 GB8901334 D0 GB 8901334D0 GB 898901334 A GB898901334 A GB 898901334A GB 8901334 A GB8901334 A GB 8901334A GB 8901334 D0 GB8901334 D0 GB 8901334D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- improvements relating
- broadhead arrows
- broadhead
- arrows
- relating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898901334A GB8901334D0 (en) | 1989-01-21 | 1989-01-21 | Improvements relating to broadhead arrows |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898901334A GB8901334D0 (en) | 1989-01-21 | 1989-01-21 | Improvements relating to broadhead arrows |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB8901334D0 true GB8901334D0 (en) | 1989-03-15 |
Family
ID=10650387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB898901334A Pending GB8901334D0 (en) | 1989-01-21 | 1989-01-21 | Improvements relating to broadhead arrows |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB8901334D0 (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
| EP4530296A2 (en) | 2016-04-27 | 2025-04-02 | AbbVie Manufacturing Management Unlimited Company | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| WO2025184208A1 (en) | 2024-02-27 | 2025-09-04 | Bristol-Myers Squibb Company | Anti-ceacam5 antibodies and uses thereof |
| WO2025196691A1 (en) | 2024-03-20 | 2025-09-25 | Janssen Biotech, Inc. | Methods of treating crohn's disease with anti-il23 specific antibody |
-
1989
- 1989-01-21 GB GB898901334A patent/GB8901334D0/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| EP4530296A2 (en) | 2016-04-27 | 2025-04-02 | AbbVie Manufacturing Management Unlimited Company | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
| WO2025184208A1 (en) | 2024-02-27 | 2025-09-04 | Bristol-Myers Squibb Company | Anti-ceacam5 antibodies and uses thereof |
| WO2025196691A1 (en) | 2024-03-20 | 2025-09-25 | Janssen Biotech, Inc. | Methods of treating crohn's disease with anti-il23 specific antibody |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0413084A3 (en) | Projectile | |
| GB8719678D0 (en) | Sub-munition | |
| ZA909920B (en) | Detonators | |
| GB2284251B (en) | Projectile | |
| GB8901334D0 (en) | Improvements relating to broadhead arrows | |
| GB8914067D0 (en) | Projectile | |
| GB2243901B (en) | Projectiles | |
| GB2213916B (en) | Projectile | |
| GR870835B (en) | Projectile | |
| GB8723428D0 (en) | Darts | |
| GB2192804B (en) | Dart | |
| EP0271480A3 (en) | Flare-carrying projectile | |
| GB8706018D0 (en) | Munitions | |
| GB8624842D0 (en) | Firecrackers | |
| GB2354310B (en) | Warhead | |
| GB8801527D0 (en) | Improvements relating to broadhead arrows | |
| GB8619039D0 (en) | Darts | |
| GB2444758B (en) | Sabot | |
| IL79191A0 (en) | Projectile | |
| GB8914921D0 (en) | Projectile | |
| EG18054A (en) | Projectiles | |
| GB2371103B (en) | Cratering munitions | |
| GB8602958D0 (en) | Darts | |
| GB8608011D0 (en) | Darts | |
| GB8624073D0 (en) | Darts |